Starting Dose of Hydralazine for Severe Hypertension (185/120 mmHg)
For a patient with severe hypertension (BP 185/120 mmHg), the starting dose of hydralazine is 10 mg via slow IV infusion, with a maximum initial dose of 20 mg, repeated every 4-6 hours as needed. 1, 2, 3
Dosing Algorithm
Initial Administration
- Start with 10 mg IV given as a slow infusion
- Maximum initial dose should not exceed 20 mg
- Expect BP to begin decreasing within 10-30 minutes
- Peak effect typically occurs between 10-80 minutes 1, 2
Repeat Dosing
- If BP remains elevated, repeat 10-20 mg every 4-6 hours as needed
- Monitor BP frequently after each dose 4
FDA-Approved Dosing (Alternative)
The FDA label specifies 20-40 mg as the usual dose, repeated as necessary, though certain patients (especially those with marked renal damage) may require lower doses 4. However, the ACC/AHA guidelines consistently recommend starting at the lower 10 mg dose for better safety.
Critical Considerations
Why Hydralazine Is NOT First-Line
Hydralazine should generally NOT be your first choice for acute severe hypertension. The guidelines explicitly state: "Unpredictability of response and prolonged duration of action do not make hydralazine a desirable first-line agent for acute treatment in most patients." 1, 2, 3
Preferred Alternatives
For hypertensive emergencies (BP 185/120 with target organ damage), consider instead:
- Nicardipine: Initial 5 mg/h IV, titrating by 2.5 mg/h every 5 minutes 1
- Labetalol: 0.3-1.0 mg/kg (max 20 mg) IV every 10 minutes 1
- Clevidipine: Initial 1-2 mg/h IV, doubling every 90 seconds 1
These agents offer more predictable responses and easier titration.
Specific Clinical Scenarios
When Hydralazine IS Appropriate
- Pregnancy-related hypertension: Hydralazine remains a reasonable option for severe hypertension in pregnancy/postpartum 5, 6, 7
Monitoring Requirements
- Check BP every 10 minutes initially
- Monitor for hypotension (occurs in ~2% of cases) 7
- Watch for reflex tachycardia and headache (more common with hydralazine than labetalol) 7
- Assess renal function, especially in patients with pre-existing kidney disease 4
Common Pitfalls
Avoid Continuous Infusion
Do NOT use continuous IV hydralazine infusion. A study showed that continuous infusion (starting at 5 mg/hr) resulted in rapid, uncontrolled BP decline causing fetal distress in 5 of 7 pregnant patients 8. Intermittent bolus dosing is safer and more controllable.
Onset and Duration Issues
- Onset: 10-30 minutes (slower than nicardipine or labetalol)
- Duration: 2-4 hours (prolonged, making overshoot hypotension harder to reverse) 1, 2
- This prolonged action means you cannot quickly adjust if BP drops too much
Side Effects to Anticipate
- Maternal tachycardia and palpitations (significantly more common than with labetalol, p=0.01) 7
- Headache
- Potential for symptomatic orthostatic hypotension 9
- Rare but serious: myocardial ischemia with ST-T changes 9
Transition to Oral Therapy
Most patients can be transitioned to oral hydralazine within 24-48 hours 4. For chronic heart failure management (if applicable), oral hydralazine dosing starts at 25-50 mg 3-4 times daily, targeting up to 300 mg total daily in divided doses 10, 11, 12, 11.